Riskpilot← Back to searchSign inGet full accessped doc AB
ABActiveOrg 5568475502Arenavägen 27 Plan 6General medical practice activities · NACE 8621Est. 201132 employees
Revenue 2024
SEK 58,4M
+25% vs 2023
EBITDA margin
1.3%
-10% vs 2023
Equity ratio
12.4%
Financial strength
Net profit 2024
SEK 433K
-29% vs 2023
| Revenue | SEK 58,4M | +25% |
| EBITDA | SEK 778K | -10% |
| Net profit | SEK 433K | -29% |
| Total assets | SEK 8,4M | +8% |
| Equity | SEK 1M | -66% |
| Employees | 32 | — |
Legal name
ped doc AB
Org number
5568475502
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 mars 2011
Share capital
SEK 50 000
Employees
32 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet avser konsult inom sjuk- och hälsovård och därmed förenlig verksamhet.
Address
Arenavägen 27 Plan 6
Phone
+46736198986
Email
hans.dekeyzer@bsmartina.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 19 879 | 24 578 | 46 484 | 43 690 | 38 976 | 46 763 | 58 408 |
| Staff expenses | — | — | — | — | — | — | — | −26 196 | −24 407 | −28 877 |
| EBITDA | 1 070 | 1 190 | 1 388 | 2 037 | 1 426 | 9 951 | 1 676 | −2 775 | 862 | 778 |
| Depreciation & amort. | −0 | −24 | −46 | −47 | −64 | −127 | −154 | −178 | −214 | −211 |
| EBIT | 1 070 | 1 166 | 1 342 | 1 990 | 1 362 | 9 824 | 1 522 | −2 952 | 648 | 566 |
| Net financials | −35 | −8 | −2 | −10 | −17 | −15 | — | −42 | −42 | −133 |
| Profit before tax | 844 | 863 | 1 495 | 2 062 | 1 499 | 10 574 | 1 252 | −2 995 | 607 | 433 |
| Tax | −192 | −196 | −349 | −460 | −361 | −2 291 | −557 | — | — | — |
| Net profit | 652 | 667 | 1 146 | 1 602 | 1 138 | 8 283 | 695 | −2 995 | 607 | 433 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 731 | 4 508 | 4 451 | 5 089 | 7 219 | 14 499 | 16 197 | 7 218 | 7 759 | 8 397 |
| Equity | 2 006 | 1 545 | 1 271 | 1 953 | 2 522 | 9 804 | 10 499 | 2 504 | 3 111 | 1 044 |
| Long-term debt | 556 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 1 309 | 1 807 | 2 180 | 2 218 | 3 934 | 4 695 | 5 698 | 4 713 | 4 648 | 7 353 |
| Total debt | 1 865 | 1 807 | 2 180 | 2 218 | 3 934 | 4 695 | 5 698 | 4 713 | 4 648 | 7 353 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20152024
Equity ratio
12.4%
This company
38.2%
Market median
-68% vs market
20152024
Return on equity
41.5%
This company
18.4%
Market median
+126% vs market
20152024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20152024
Asset turnover
6.96×
This company
1.12×
Market median
+521% vs market
20152024
Debt / equity
7.04×
This company
0.62×
Market median
-1035% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NT Chief Auditor | Chief Auditor | 2025 | — | — |
KK Chief Auditor | Chief Auditor | 2022 | — | — |
Hd Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Barnsjukhuset Martina i Stockholm AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lobus AB
ped doc AB Board members of ped doc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Thomas Gustavsson | Chief Auditor | 0 companies |
| Kajsa Karin Helena Goding | Chief Auditor | 0 companies |
| Hans de Keyzer | Chief Executive Officer | 0 companies |
| Claude André Kollin | Chairman | 0 companies |
| Petra Verbovszki | Deputy Board Member | 0 companies |